Literature DB >> 21357726

GDNF and protection of adult central catecholaminergic neurons.

Alberto Pascual1, María Hidalgo-Figueroa, Raquel Gómez-Díaz, José López-Barneo.   

Abstract

Neurotrophic factors are small proteins necessary for neuron survival and maintenance of phenotype. They are considered as promising therapeutic tools for neurodegenerative diseases. The glial cell line-derived neurotrophic factor (GDNF) protects catecholaminergic cells from toxic insults; thus, its potential therapeutic applicability in Parkinson's disease has been intensely investigated. In recent years, there have been major advances in the analysis of GDNF signaling pathways in peripheral neurons and embryonic dopamine mesencephalic cells. However, the actual physiological role of GDNF in maintaining catecholaminergic central neurons during adulthood is only starting to be unraveled, and the mechanisms whereby GDNF protects central brain neurons are poorly known. In this study, we review the current knowledge of GDNF expression, signaling, and function in adult brain, with special emphasis on the genetic animal models with deficiency in the GDNF-dependent pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21357726     DOI: 10.1530/JME-10-0125

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  27 in total

1.  Alcohol consumption induces global gene expression changes in VTA dopaminergic neurons.

Authors:  K Marballi; N K Genabai; Y A Blednov; R A Harris; I Ponomarev
Journal:  Genes Brain Behav       Date:  2015-12-28       Impact factor: 3.449

2.  Effect of hyperoxic exposure during early development on neurotrophin expression in the carotid body and nucleus tractus solitarii.

Authors:  Raul Chavez-Valdez; Ariel Mason; Ana R Nunes; Frances J Northington; Clarke Tankersley; Rajni Ahlawat; Sheree M Johnson; Estelle B Gauda
Journal:  J Appl Physiol (1985)       Date:  2012-03-15

3.  The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions.

Authors:  Tanuja Bordia; Matthew McGregor; Roger L Papke; Michael W Decker; J Michael McIntosh; Maryka Quik
Journal:  Exp Neurol       Date:  2014-09-28       Impact factor: 5.330

Review 4.  A synopsis on the role of tyrosine hydroxylase in Parkinson's disease.

Authors:  Shams Tabrez; Nasimudeen R Jabir; Shazi Shakil; Nigel H Greig; Qamre Alam; Adel M Abuzenadah; Ghazi A Damanhouri; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-06-01       Impact factor: 4.388

Review 5.  Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.

Authors:  Robert D Wyse; Gary L Dunbar; Julien Rossignol
Journal:  Int J Mol Sci       Date:  2014-01-23       Impact factor: 5.923

6.  Increased Mmp/Reck Expression Ratio Is Associated with Increased Recognition Memory Performance in a Parkinson's Disease Animal Model.

Authors:  Adauto Spindola; Adriano D S Targa; Lais Soares Rodrigues; Sheila Maria Brochado Winnischofer; Marcelo M S Lima; Mari Cleide Sogayar; Marina Trombetta-Lima
Journal:  Mol Neurobiol       Date:  2019-09-06       Impact factor: 5.590

7.  Glial cell-derived neurotrophic factor attenuates neuropathic pain in a mouse model of chronic constriction injury: possible involvement of E-cadherin/p120ctn signaling.

Authors:  Cunjin Wang; Hongjun Wang; Jun Pang; Li Li; Suming Zhang; Ge Song; Na Li; Junping Cao; Licai Zhang
Journal:  J Mol Neurosci       Date:  2014-03-06       Impact factor: 3.444

8.  The proform of glia cell line-derived neurotrophic factor: a potentially biologically active protein.

Authors:  Xiao-Long Sun; Bei-Yu Chen; Li Duan; Yi Xia; Zhuo-Jing Luo; Jing-Jie Wang; Zhi-Ren Rao; Liang-Wei Chen
Journal:  Mol Neurobiol       Date:  2013-08-10       Impact factor: 5.590

9.  The potential neuroprotection mechanism of GDNF in the 6-OHDA-induced cellular models of Parkinson's Disease.

Authors:  Feng Li; Meng Wang; Shuan Zhu; Li Li; Ye Xiong; Dian-Shuai Gao
Journal:  Cell Mol Neurobiol       Date:  2013-07-12       Impact factor: 5.046

Review 10.  Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors.

Authors:  Jie Wang; Wei-Wei Hu; Zhi Jiang; Mei-Jiang Feng
Journal:  World J Stem Cells       Date:  2020-05-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.